1. A medicinal product for a human or animal other than a human, containing a combination of general anesthetic and hydrogen, intended to prevent and / or alleviate neurological deficit induced by anesthetics. 2. A medicinal product for general anesthesia of a human or animal other than a human, intended to prevent and / or alleviate neurological deficit induced by anesthetics, characterized in that the general anesthetic and hydrogen are administered in combination. 3. The medicament according to claim 1, wherein the neurological deficit induced by anesthetics is associated with neural apoptosis. A medicament for preventing and / or alleviating neurological deficit induced by anesthetics containing a general anesthetic, where a general anesthetic is used in combination with hydrogen. 5. The drug according to any one of paragraphs. 1-4, where the general anesthetic is an anesthetic for inhalation or a liquid anesthetic for intravenous administration and hydrogen is hydrogen gas. The medicament according to claim 5, wherein the concentration of hydrogen gas in the medicament is 0.15-7% (v / v). The drug according to any one of paragraphs. 1-4, where the drug is intended for the fetus, newborn, infant, preschool child, minor or elderly adult8. The drug according to any one of paragraphs. 1-4, where the general anesthetic is one or more types of anesthetics selected from the group consisting of nitrous oxide, isoflurane, enflurane, methoxyflurane, sevoflurane, desflura1. Лекарственный препарат для человека или животного, иного чем человек, содержащий сочетание анестетика общего действия и водорода, предназначенный для предотвращения и/или облегчения индуцируемого анестетиками неврологического дефицита.2. Лекарственный препарат для общей анестезии человека или животного, иного чем человек, предназначенный для предотвращения и/или облегчения индуцируемого анестетиками неврологического дефицита, отличающийся тем, что анестетик общего действия и водород вводятся в сочетани
